Ambulatory Fibrinolysis in the Management of Septated Malignant Effusions

Arch Bronconeumol (Engl Ed). 2019 Nov;55(11):594-596. doi: 10.1016/j.arbres.2019.04.002. Epub 2019 May 24.

[Article in English, Spanish]

Authors

Julia Herrero Huertas¹, Francisco Julián López González², Lucía García Alfonso³, Ana Isabel Enríquez Rodríguez²

Affiliations

¹ Servicio de Neumología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España. Electronic address: [email protected].
² Servicio de Neumología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España.
³ Servicio de Neumología, Complexo Hospitalario Universitario A Coruña, A Coruña, España.

PMID: 31133356
DOI: 10.1016/j.arbres.2019.04.002

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Ambulatory Care / methods
Carcinoma, Renal Cell / secondary
Fibrinolytic Agents / therapeutic use*
Humans
Kidney Neoplasms / pathology
Male
Middle Aged
Pleural Effusion, Malignant / diagnostic imaging
Pleural Effusion, Malignant / drug therapy*
Pleural Effusion, Malignant / etiology
Thoracentesis
Urokinase-Type Plasminogen Activator / therapeutic use*

Substances

Fibrinolytic Agents
Urokinase-Type Plasminogen Activator